1. What Happened?
On August 18, 2025, Meta X No.1 Partnership acquired a 40.36% stake in Jayjun Cosmetic, becoming the largest shareholder. This acquisition, with the stated purpose of ‘influencing management,’ signals an active role in the company’s operations.
2. Why Does It Matter?
Jayjun Cosmetic is facing severe financial challenges, including declining sales, increasing operating losses, and a substantial accumulated deficit. Furthermore, the company is dealing with ongoing lawsuits. The change in management is a crucial factor that could significantly impact its future. While exploring new ventures in healthcare and financial investment, the success of these initiatives remains uncertain.
3. What’s Next?
- Positive Scenario: Meta X No.1 Partnership’s financial resources and management expertise could lead to positive changes, including restructuring, successful new ventures, and improved financial health.
- Negative Scenario: Uncertainty surrounding the new management’s strategy, short-term difficulties due to restructuring, and increased lawsuit risks could negatively impact the company.
4. What Should Investors Do?
A ‘conservative wait-and-see’ approach is recommended for Jayjun Cosmetic investments. Investors should closely monitor the new management’s plans, the recovery of core businesses, the progress of new ventures, and the management of lawsuit risks.
Why is Meta X No.1 Partnership’s takeover of Jayjun Cosmetic significant?
Jayjun Cosmetic is currently facing financial difficulties. The new management’s arrival is a critical factor that could determine the company’s future.
What is the outlook for Jayjun Cosmetic?
The outlook depends on the new management’s strategy. It could be positive or negative. Closely monitor new ventures, lawsuit risks, and other key factors.
What should investors pay attention to?
Investors should carefully monitor the new management’s plans, core business recovery, new venture progress, and lawsuit risk management. A ‘conservative wait-and-see’ approach is recommended.